Effective treatment of leukemia cutis with combination of rituximab, cladribine, and cyclophosphamide in patient with B-cell chronic lymphocytic leukemia

Ann Hematol. 2011 Aug;90(8):979-80. doi: 10.1007/s00277-010-1109-8. Epub 2010 Oct 27.

Authors

Aleksandra Batycka-Baran, Wojciech Baran, Justyna Dzietczenia, Grzegorz Mazur

PMID: 20978760
DOI: 10.1007/s00277-010-1109-8

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Murine-Derived / therapeutic use
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Cladribine / therapeutic use
Cyclophosphamide / therapeutic use
Diagnostic Errors
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
Leukemia, Lymphocytic, Chronic, B-Cell / pathology*
Middle Aged
Remission Induction
Rituximab
Rosacea / diagnosis

Substances

Antibodies, Monoclonal, Murine-Derived
Cladribine
Rituximab
Cyclophosphamide